China SXT Pharmaceuticals Inc.
SXTC | NASDAQ
$2.93
-$0.05 (-1.68%)
At close: Nov 5, 2026, 4:00 PM ET
$2.90
-$0.03 (-1.02%)
After-hours:
Nov 5, 2026, 7:28 PM ET
Company Profile
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Key Executives
| Name | Position |
|---|---|
| Feng Zhou | Chairman of the Board & Co-CEO |
| Sze Beng Lim | Co-Chief Executive Officer |
| Xiaodong Pan | Chief Financial Officer |
| Jun Zheng | Executive Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 21, 2026 | 6-K | Filing |
| Oct 15, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Oct 09, 2026 | 6-K | Filing |
| Oct 09, 2026 | 424B5 | Filing |
| Oct 08, 2026 | 6-K | Filing |
| Oct 08, 2026 | 6-K | Filing |
| Sep 16, 2026 | EFFECT | Filing |
| Aug 28, 2026 | F-3/A | [Amend] Filing |
| Aug 28, 2026 | 6-K | Filing |
| Jul 24, 2026 | 6-K | Filing |
China SXT Pharmaceuticals Inc.
| Country | China |
| IPO Date | Jan 4, 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 56 |
| CEO | Feng Zhou |
Contact Details
178 Taidong Road North Taizhou,
JS 225300 China
Stock Details
| Ticker Symbol | SXTC |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001723980 |
| CUSIP Number | G2161P181 |
| ISIN Number | VGG2161P1817 |
| SIC Code | 2834 |
Recent News
- 15 days ago / prnewswire.comChina SXT Pharmaceuticals, Inc. Announces Share Consolidation
- 16 days ago / prnewswire.comChina SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
- 27 days ago / globenewswire.comUnivest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
- 29 days ago / prnewswire.comChina SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering
Add to Watchlist
Select watchlists to add or remove SXTC